Low-molecular weight heparin: Treatment failure in a patient with primary antiphospholipid antibody syndrome

American Journal of the Medical Sciences

Volumn 324, Issue 5, 2002, Pages 279-280

  Ahmed, Shahid ^a   Karim, Anita ^a   Patel, Dilip ^a   Siddiqui, Rina ^b   Mattana, Joseph ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Antiphospholipid antibody syndrome; Low molecular weight heparin; Treatment failure

Indexed keywords

ANTICOAGULANT AGENT; ARGATROBAN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG EMBOLISM; RECURRENT ABORTION; THROMBOSIS; TREATMENT FAILURE;

EID: 0036842031     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200211000-00008     Document Type: Article

References (12)

1. Petri M. Pathogenesis and treatment of antiphospholipid antibody syndrome. Med Clin North Am 1997;81:151-77.
2. Kandiah DA, Sali A, Sheng Y, et al. Current insight into the antiphospholipid syndrome: Clinical, immunological, and molecular aspects. Adv Immunol 1998;70:507-63.
3. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 1999;353:1348-53.
4. Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995;332:993-7.
5. Weitz JI. Low-molecular weight heparin. N Engl J Med 1997;337:688-98.
6. Hyers TM, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001;119:176S-93S.
7. Kitchen S, Iampietro R, Woolley AM, et al. Anti Xa monitoring during treatment with low molecular weight heparin or danaparoid: Inter-assay variability. Thromb Haemost 1999;82:1289-93.
8. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995;332:1330-5.
9. Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome. Clues to the pathogenesis from a series of 80 patients. Medicine 2001;80:355-77
10. Van der Heijden JF, Prins MH, Buller HR. Low-molecular-weight heparins: are they interchangeable? Haemostasis 2000;30 Suppl 2:148-57.
11. Weitz J, Hirsh J. New anticoagulant drugs. Chest 2001;119:95S-107S
12. Levine JS, Branch W, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-63.